This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why it is Worth Holding on to Allegion (ALLE) Stock Now
by Zacks Equity Research
Allegion (ALLE) is poised to gain from solid demand for electronic security products, effective pricing actions and buyouts. Rising costs and forex woes are creating headwinds.
Fortune Brands Gains From Segmental Health Despite High Costs (Revised)
by Zacks Equity Research
Fortune Brands (FBHS) is poised to gain from solid segmental growth opportunities, buyouts and high rewards to shareholders. Rising costs and debts are creating headwinds.
Here's Why it is Worth Holding on to Applied Industrial Stock
by Zacks Equity Research
Applied Industrial (AIT) is likely to gain from the strong Service Center-Based Distribution segment and buyouts. High costs and weakness in the Fluid Power & Flow Control segment are concerning.
The Zacks Analyst Blog Highlights: Chart Industries, Dover, Flowserve, AZZ and Manitowoc
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chart Industries, Dover, Flowserve, AZZ and Manitowoc
Silgan (SLGN) Rides on Acquisitions, Material Costs High
by Zacks Equity Research
Since its inception, Silgan Holdings (SLGN) has acquired 35 businesses and improved market share in each of its segments.
Greif (GEF) Rides on Caraustar Acquisition Amid Debt Burdens
by Zacks Equity Research
The Caraustar buyout strengthens Greif's (GEF) leadership in industrial packaging as well as significantly bolsters its margins, free cash flow and profitability.
Here's Why You Should Consider Buying AZZ Stock Right Now
by Zacks Equity Research
AZZ is likely to gain from acquired assets, strengthening growth opportunities in Energy and Metal coatings segments, and shareholder-friendly policies.
Middleby's Ss Brewtech Buyout Enhances Beverage Portfolio
by Zacks Equity Research
Middleby's (MIDD) Ss Brewtech buyout is likely to expand offerings in the beverage industry. Ss Brewtech will work as an independent unit within Middleby.
II-VI Unveils High Power Laser Bars & Semi-Framed Stack
by Zacks Equity Research
II-VI's (IIVI) high power laser bars and new simplified semi-framed stack structures, along with fully automated optical alignment processes will enable it to offer modular assemblies at optimum cost.
Broadwind (BWEN) Clinches New Tower Orders Worth $29 Million
by Zacks Equity Research
Broadwind's (BWEN) production for new towers is scheduled to begin in the fourth quarter of 2019 through 2020.
Industrial Production Hits 6-Month High in May: 5 Top Picks
by Nalak Das
A strong and broad-based gain in U.S. factory output provided some respite to concern that the manufacturing sector is cooling in the face of a lingering trade war with China.
Parker-Hannifin's Fuel Atomization Nozzles Chosen by Vericor
by Zacks Equity Research
Parker-Hannifin's (PH) fuel atomization nozzle and dual fuel manifold assembly will boost combustion performance of Vericor's oil field gas turbine.
Here's Why it is Worth Holding on to Cintas (CTAS) Stock Now
by Zacks Equity Research
Cintas (CTAS) is well placed to reap benefits of its enterprise resource planning system, buyouts and solid product portfolio. However, high integration costs and huge debts are concerning.
Caterpillar's May Sales Growth of 6% Hits Year's Lowest Point
by Zacks Equity Research
Caterpillar's (CAT) global machine sales growth rate chart has been in the single digits so far this year, at levels last witnessed in 2017.
Fortune Brands Gains From Segmental Health Despite High Costs
by Zacks Equity Research
Fortune Brands (FBHS) is poised to gain from solid segmental growth opportunities, buyouts and high rewards to shareholders. Rising costs and debts are creating headwinds.
Lindsay Banks on Infrastructure Business Amid Higher Costs
by Zacks Equity Research
Lindsay (LNN) remains focused on simplifying its business in order to improve productivity in the wake of weak agricultural demand.
Dover's (DOV) DFS Introduces Advanced Fuel Dispenser Series
by Zacks Equity Research
Dover's (DOV) DFS's Tokheim Quantium 510M provides more model options and features to customers with an enriched dispenser head.
Middleby (MIDD) Displays Bright Prospects, Risks Persist
by Zacks Equity Research
Strong demand from the domestic restaurant chain customers, and strength in beverage end market and Viking business are expected to boost Middleby's (MIDD) growth. High cost of sales is a concern.
AGCO Corp Stock Rallies 29% YTD: What's Working in Favor?
by Zacks Equity Research
Forecast-topping earnings performance during the March-end quarter and an upbeat outlook contribute to the run-up in AGCO Corp's (AGCO) shares.
Here's Why TriMas Stock is an Attractive Investment Option
by Zacks Equity Research
Apart from forecast topping earnings, strong demand, product pipeline let's have a look at some other factors that make TriMas (TRS) a compelling choice at the moment.
Chart Industries (GTLS) Prices 3.5M Common Share Offering
by Zacks Equity Research
Chart Industries (GTLS) announces pricing of 3.5 million common shares. The raised amount will be used for funding a buyout deal signed with Harsco and paying debts.
Milacron Plunges 38% in a Year: What's Ailing the Stock?
by Zacks Equity Research
Milacron Holdings (MCRN) intends to mitigate the tariffs-related headwinds by focusing on pricing actions, negotiations with existing vendors and making supply chain modifications.
Enersys (ENS) to Increase Thin Plate Pure Lead Capacity
by Zacks Equity Research
Enersys (ENS) intends to increase Thin Plate Pure Lead capacity and continue efforts of commercialization for GreenSeal Bi-Polar battery technology.
Here's Why You Should Hold Deere Stock in Your Portfolio Now
by Zacks Equity Research
With solid equipment demand, focus on the Wirtgen acquisition and long-term opportunities, Deere (DE) is worth retaining in the portfolio at the moment.
AptarGroup Acquires 2 Companies to Expand Pharma Services
by Zacks Equity Research
The acquisitions of Nanopharm and Gateway Analytical aid AptarGroup's (ATR) pharma to support customers' complex drug formulations and delivery requirements.